causal
Analysis v1
81
Pro
0
Against

The injection makes the waist smaller relative to the hips, giving a less 'apple-shaped' body and more 'pear-shaped' proportions.

Scientific Claim

Tesamorelin (2 mg subcutaneous daily) reduces waist-hip ratio by a statistically significant amount in HIV-infected adults on antiretroviral therapy with abdominal fat accumulation over 6 months, indicating improved body fat distribution.

Original Statement

Trunk fat (P < 0.001), waist circumference (P = 0.02), and waist-hip-ratio (P = 0.001) improved, with no change in limb or abdominal SC fat.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The RCT design and strong statistical significance (P = 0.001) support definitive causal language for this clinically relevant anthropometric change.

Evidence from Studies

Supporting (1)

81

This study found that a daily shot of tesamorelin helped HIV patients with belly fat lose fat around their waist and improve their waist-to-hip shape, and it worked better than a placebo.

Contradicting (0)

0
No contradicting evidence found